Auro Laboratories Ltd.
BSE: 530233
₹259.00
₹0.45
(0.17%)
As on 18-Jun-2026 13:32IST
Market cap
₹161 Cr
Revenue (TTM)
₹31 Cr
P/E Ratio
45.6
P/B Ratio
3.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹4 Cr
-
ROE
4.3 %
-
ROCE
3.8 %
-
Industry P/E
50.71
-
EV/EBITDA
14.9
-
Debt to Equity
0
-
Book Value
₹74.4
-
EPS
₹5.8
-
Face value
10
-
Shares outstanding
6,232,500
10 Years Aggregate
CFO
₹68.73 Cr
EBITDA
₹61.19 Cr
Net Profit
₹35.78 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Auro Laboratories
| 3.8 | -3.3 | -6.2 | -2.1 | 41.7 | 18.4 | 27.7 |
|
BSE Healthcare
| 9.0 | 0.3 | 11.4 | 9.1 | 23.6 | 13.7 | 12.3 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Auro Laboratories
| -5.2 | 97.6 | 64.2 | -26.9 | 30.0 | 76.3 | -15.8 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Auro Laboratories
|
259.0 | 161.1 | 30.8 | 3.5 | 22.6 | 8.1 | 45.6 | 3.5 |
| 1,058.9 | 12,884.0 | 2,551.8 | 564.5 | 28.3 | 18.4 | 22.8 | 3.9 | |
| 515.8 | 8,765.2 | 947.3 | 247.8 | 28.5 | 18.9 | 35.4 | 6.4 | |
| 1,351.2 | 14,025.4 | 1,054.9 | 256.3 | 27.8 | 13.7 | 53.8 | 7.0 | |
| 1,738.8 | 32,685.9 | 9,203.5 | 941.3 | 15.4 | 19.6 | 35.4 | 6.6 | |
| 375.0 | 4,155.4 | 165.8 | 46.7 | 37.8 | 16.9 | 89 | 14.4 | |
| 17,177.0 | 21,810.5 | 2,023.0 | 364.0 | 23.9 | 20.8 | 59.9 | 11.6 | |
| 1,016.1 | 5,244.4 | 811.3 | 21.0 | 0.7 | 2.1 | 255.2 | 4.1 | |
| 1,337.5 | 5,850.9 | 649.5 | 121.6 | 23.7 | 13.2 | 50.7 | 6.3 | |
| 260.0 | 6,918.7 | 7.1 | -276.3 | -4,077.5 | -63.3 | -- | 11.7 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Auro Laboratories
Auro Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs), intermediates, and generic formulations in India. It offers APIs for various drugs, such as antihistamine, muscle relaxant, diuretic, iron deficiency,... anti-diabetic, anti-fungal, anti-ulcer, iodine supplement, anti-malaria, analgesics, antacids, and anti-inflammatory, as well as for other products, including potassium iodide, sodium iodide, and microcrystalline cellulose. The company also provides specialty chemicals comprising guanidine nitrate; dimethyl amine HCl; 2-ethoxy benzoic acid; and trimethoxy benzoic acid. In addition, it offers intermediates consisting of glibenclamde sulphonamide for use in API glibenclamide; cis-bramo benzoate and cls-tosylate that are used in API Ketoconazol; trimethoxy benzoic acid; 2-ethoxy benzoic acid for use in API sildenafil citrate; and 5-bromo phthalide that is used in API citalopram. It also exports products to Egypt, Germany, Malaysia, Singapore, South Africa, Brazil, Spain, and the United Kingdom. Auro Laboratories Limited was incorporated in 1989 and is based in Mumbai, India. Read more
-
Incorporated
1989
-
Chairman
Sharat Deorah
-
Managing Director
Sharat Deorah
-
Headquarters
Thane, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsResults For The Year Ended March 31 2026
29-May-2026Board Meeting Outcome for Held On May 29 2026
29-May-2026No News & Announcements are available.
FAQs for Auro Laboratories
What is the current share price of Auro Laboratories Ltd Today?
The share price of Auro Laboratories Ltd is ₹259.00 (BSE) as of 18-Jun-2026 13:32 IST. Auro Laboratories Ltd has given a return of 41.67% in the last 3 years.
What is the current PB & PE ratio of Auro Laboratories Ltd?
The P/E ratio of Auro Laboratories Ltd is 45.61 times as on 17-Jun-2026, a 10 discount to its peers’ median range of 50.71 times.
The P/B ratio of Auro Laboratories Ltd is 3.48 times as on 17-Jun-2026, a 10 discount to its peers’ median range of 3.87 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
78.15
|
3.34
|
|
2024
|
12.89
|
2.39
|
|
2023
|
13.95
|
1.00
|
|
2022
|
21.98
|
1.98
|
|
2021
|
7.04
|
1.77
|
What is the 52 Week High and Low of Auro Laboratories Ltd?
The 52-week high and low of Auro Laboratories Ltd are Rs 317.00 and Rs 159.00 as of 18-Jun-2026.
What is the market cap of Auro Laboratories Ltd?
Auro Laboratories Ltd has a market capitalisation of ₹ 161 Cr as on 17-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Auro Laboratories Ltd?
Before investing in Auro Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.